Home | | Clinical Cases in Anesthesia | What should a preoperative evaluation of this patient include?

Chapter: Clinical Cases in Anesthesia : Liver Disease

What should a preoperative evaluation of this patient include?

Preoperative evaluation of patients with liver disease focuses on symptoms of liver dysfunction.

What should a preoperative evaluation of this patient include?

 

Preoperative evaluation of patients with liver disease focuses on symptoms of liver dysfunction. Examples are easy bruising, bleeding problems, mental status changes, and dyspnea on exertion or at rest. Portal hypertension predisposes to upper gastrointestinal bleeding from esophageal varices. Additionally, portal flow obstruction can lead to the shunting of toxins and bacteria absorbed by the gastrointestinal system directly into the systemic circu-lation, putting these patients at increased risk for infection and sepsis.

 

In evaluating the patient with a history of liver disease, it is extremely important to note the degree of liver dam-age and remaining function. Although no specific single test can determine liver function, selected preoperative tests can give significant insight into the degree of liver function remaining.

 

Albumin is synthesized in the liver and has a long (20 days) half-life. Its serum levels are a result of balancing losses against production. Factors responsible for increased loss of albumin include massive ascites from various causes and renal disease. Decreased production can result from poor nutritional status and decreased hepatic synthesis. Thus, albumin levels may indicate the degree of hepatic dysfunction more in chronic liver disease than in fulmi-nant hepatic failure.

 

A good laboratory indicator of liver function in both acute and chronic liver disease is the prothrombin time (PT). It is a measure of factors I, II, V, VII, and X. These factors are produced by the liver and require several inter-mediate steps, which is a reflection of the liver’s synthetic function. Not only is the PT a good test of liver function, it is also a good prognosticator of outcome following surgery in patients with liver disease. It should be noted that vita-min K deficiency, disseminated intravascular coagulation, fibrinolysis, and coumadin administration all prolong PT independently of liver disease.

 

Transaminases are enzymes that help transfer amino groups from amino acids to ketoacids. In the setting of liver cell injury, transaminases leak into the plasma increas-ing blood levels. They serve as indicators of liver damage; however, they have significant limitations as determinants of liver function. In advanced chronic liver disease, transaminase levels may actually be normal or low. This is secondary to massive loss of liver parenchymal tissue. Although they have little prognostic value, transaminase levels are commonly followed throughout the periopera-tive course.

 

Just as risk of cardiac injury has been studied in non-cardiac surgery, the risk of nonhepatic surgery in patients with significant liver disease has also been well studied. The Child’s classification stratifies mortality risk of portosystemic shunting in patients with mild, moderate, or severe liver disease. Mortality ranged from 5% to 50%, depending on the severity of the disease. This classification has been modified, the Child-Turcotte-Pugh (CTP) score (Table 35.1), which now includes the PT and other variables. Patients with scores ≥7 are qualified to be listed for liver transplant, whereas those with a score ≥10 are considered to have sig-nificant liver disease.


Other useful preoperative tests would include a hemat-ocrit, platelet count, glucose, electrolyte profile, and a blood urea nitrogen (BUN) and creatinine. An electrocardiogram (ECG) is recommended because of the associated cardiac problems in these patients. A detailed physical examination of the airway, neck, heart, and lungs should be performed.

 

Recently, a new system was established to improve evaluation and allocation of donor livers for patients with ESLD: the model for end-stage l iver d isease (MELD). A MELD score is obtained based on objective and verifiable medical data that evaluates the patient’s risk of dying while waiting for a liver transplant. This numerical scale is currently used for liver allocation. Further information can be obtained from the UNOS (www. unos.org/ resources).

 

Study Material, Lecturing Notes, Assignment, Reference, Wiki description explanation, brief detail
Clinical Cases in Anesthesia : Liver Disease : What should a preoperative evaluation of this patient include? |


Privacy Policy, Terms and Conditions, DMCA Policy and Compliant

Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.